Rectal Bleeding: When to See a Doctor and What Causes It

Why Rectal Bleeding Happens

Rectal bleeding (hematochezia) occurs when blood vessels in the lower gastrointestinal tract are damaged, inflamed, or structurally abnormal. The color and volume of blood offer the first clue to its origin. Bright red blood typically points to a source in the rectum, anus, or sigmoid colon, while darker or maroon-colored blood suggests a source higher in the colon or small bowel.

The anatomy matters. The hemorrhoidal venous plexus sits just inside the anal canal. It engorges under pressure from straining, prolonged sitting, pregnancy, or chronic constipation. When these cushions swell beyond their capacity, the thin mucosal surface tears and bleeds [1]. Hemorrhoids remain the single most frequent cause of rectal bleeding in adults under 50, responsible for an estimated 40% of presentations in primary care settings [2].

Anal fissures rank second. A fissure is a small linear tear in the anoderm, usually at the posterior midline, caused by passage of hard stool. The pain is sharp and immediate. Bleeding is typically minimal, bright red, and visible on toilet paper rather than mixed into the stool.

Beyond these benign causes, the differential diagnosis widens quickly. Diverticular disease, colorectal polyps, inflammatory bowel disease (IBD), infectious colitis, angiodysplasia, and colorectal cancer all present with rectal bleeding [3]. A 2020 meta-analysis published in the BMJ found that the positive predictive value of rectal bleeding for colorectal cancer in primary care was 3.4% overall, rising to 8.1% in patients aged 70 and older [4]. That means the vast majority of bleeding is benign, but the stakes of a missed malignancy are high enough that evaluation is always warranted when red-flag features are present.

When to See a Doctor: The Red-Flag Checklist

See a doctor within one to three days if rectal bleeding is new, recurrent, or accompanied by any alarm feature. Seek emergency care immediately if bleeding is heavy and continuous, you feel lightheaded or faint, or your heart is racing.

The American Gastroenterological Association (AGA) and the British Society of Gastroenterology (BSG) both outline specific alarm features that should prompt urgent referral [5]. These include:

• Age 45 or older without a completed colonoscopy in the past 10 years
• Change in bowel habits lasting more than 4 weeks (new constipation, diarrhea, or pencil-thin stools)
• Unintentional weight loss exceeding 5% of body weight over 6 months
• A palpable abdominal or rectal mass on exam
• Iron-deficiency anemia, especially in men or postmenopausal women
• Family history of colorectal cancer or hereditary polyposis syndromes

Dr. David Johnson, professor of gastroenterology at Eastern Virginia Medical School, has stated: "Any patient over 45 with rectal bleeding who has not been screened should be referred for colonoscopy, period. The assumption that it's hemorrhoids is the most dangerous assumption in GI medicine" [6].

Volume alone is not a reliable guide to severity. Small-volume, intermittent bleeding from a right-sided colon cancer can be occult for months before becoming visible. A single episode of painless bright red bleeding in a 25-year-old with known hemorrhoids is low risk. The same episode in a 55-year-old with a family history of colon cancer is a different clinical scenario entirely.

Common Causes of Rectal Bleeding

Hemorrhoids, fissures, and diverticulosis account for more than 75% of all cases of overt lower GI bleeding in adults [7]. Each has a distinct presentation pattern that helps guide initial assessment.

Hemorrhoids. Internal hemorrhoids bleed painlessly. The blood is bright red and often drips into the toilet bowl or streaks the stool surface. External hemorrhoids hurt more than they bleed, especially when thrombosed. The U.S. prevalence of symptomatic hemorrhoids is approximately 4.4%, though community surveys suggest up to 40% of adults have hemorrhoidal changes on examination [1].

Anal fissures. Pain during and after defecation is the hallmark. Bleeding is minimal. Acute fissures heal with dietary fiber, adequate hydration, sitz baths, and topical nitroglycerin or diltiazem in 80% to 90% of cases within 6 to 8 weeks [8].

Diverticular bleeding. Typically sudden, painless, and sometimes massive. Diverticular disease affects roughly 60% of adults over age 60 in Western populations [9]. Most diverticular bleeds stop spontaneously (about 70% to 80%), but recurrence rates reach 25% within 4 years [7].

Colorectal polyps and cancer. Adenomatous polyps may bleed intermittently and are often detected only by colonoscopy or fecal immunochemical testing (FIT). The U.S. Preventive Services Task Force (USPSTF) recommends screening for colorectal cancer in all adults aged 45 to 75, with colonoscopy every 10 years, FIT annually, or stool DNA testing every 1 to 3 years as acceptable options [10].

Inflammatory bowel disease. Ulcerative colitis classically presents with bloody diarrhea, urgency, and tenesmus. Crohn's disease may cause rectal bleeding but more often presents with abdominal pain, diarrhea, and weight loss. The combined prevalence of IBD in the United States is approximately 1.3% of adults, or about 3.1 million people, according to 2023 CDC estimates [11].

Angiodysplasia. Vascular malformations in the cecum or ascending colon are a common cause of recurrent bleeding in patients over 60, particularly those with chronic kidney disease or aortic stenosis [7].

How Rectal Bleeding Is Diagnosed

The diagnostic workup begins with a careful history and a digital rectal examination (DRE). Colonoscopy is the definitive test when bleeding is persistent, unexplained, or associated with alarm symptoms.

Your doctor will ask about stool color, volume, frequency, associated pain, and any changes in bowel habits. A DRE can identify hemorrhoids, fissures, masses, and stool characteristics. Blood work typically includes a complete blood count (CBC) to check for anemia and iron studies if chronic blood loss is suspected.

Fecal immunochemical test (FIT). This non-invasive stool test detects human hemoglobin in feces with a sensitivity of approximately 74% for colorectal cancer and 24% for advanced adenomas, according to a 2014 systematic review in Annals of Internal Medicine [12]. A positive FIT in any patient warrants follow-up colonoscopy.

Colonoscopy. The gold standard. It allows direct visualization of the entire colon and rectum, biopsy of suspicious lesions, and therapeutic intervention (polypectomy, cauterization, clipping) in a single session. The AGA recommends colonoscopy within 8 weeks for patients with rectal bleeding and alarm features [5].

Flexible sigmoidoscopy. Examines only the left colon and rectum. Useful in younger patients (<40) with bright red bleeding and a clinical picture consistent with hemorrhoids or fissures, but it misses right-sided pathology.

CT angiography. Reserved for acute, heavy lower GI bleeding when the patient is hemodynamically unstable and colonoscopy cannot be safely performed. It can detect bleeding rates as low as 0.3 to 0.5 mL per minute [13].

Capsule endoscopy. Occasionally used when colonoscopy and upper endoscopy fail to identify a bleeding source, suggesting a small-bowel origin (obscure GI bleeding).

Treatment for Rectal Bleeding

Treatment depends entirely on the underlying cause. For hemorrhoids and fissures, conservative measures work in most patients. For diverticular bleeds, colonoscopic intervention or angiographic embolization may be necessary. For colorectal cancer, early detection through screening is the single most effective intervention.

Hemorrhoid management. First-line therapy includes dietary fiber supplementation (25 to 30 grams daily), adequate fluid intake, avoidance of straining, and topical agents. A Cochrane review of fiber supplementation for hemorrhoids found a 47% reduction in the risk of persistent bleeding compared to non-fiber controls (RR 0.53, 95% CI 0.38 to 0.73) [14]. Office-based procedures for grade II and III internal hemorrhoids include rubber band ligation (the most effective non-surgical option, with success rates of 60% to 80%), infrared coagulation, and sclerotherapy [1]. Surgical hemorrhoidectomy is reserved for grade IV hemorrhoids or failed office-based treatment.

Anal fissure management. Acute fissures respond to fiber, stool softeners, warm sitz baths (10 to 15 minutes, two to three times daily), and topical 0.2% to 0.4% nitroglycerin ointment or 2% diltiazem cream [8]. Chronic fissures (present for more than 8 weeks) may require botulinum toxin injection into the internal anal sphincter or lateral internal sphincterotomy.

Diverticular bleeding. Most episodes resolve with supportive care (IV fluids, blood transfusion if needed, bowel rest). Colonoscopic hemostasis with clips or epinephrine injection is performed when an active bleeding source is identified. For recurrent or massive bleeding, angiographic embolization or segmental colectomy may be required [7].

IBD-related bleeding. Treatment targets the underlying inflammation. For ulcerative colitis, mesalamine (5-ASA) is first-line for mild to moderate disease, while biologic agents (infliximab, vedolizumab, ustekinumab) are used for moderate to severe disease. The PURSUIT trial (N=774) demonstrated that golimumab induced clinical response in 51% of anti-TNF-naive patients with moderate-to-severe ulcerative colitis at week 6, compared to 30.3% with placebo [15].

Colorectal cancer screening and polyp removal. Colonoscopic polypectomy reduces colorectal cancer incidence by 40% to 60% based on data from the National Polyp Study [16]. The USPSTF gives colorectal cancer screening an "A" recommendation for adults aged 45 to 75 [10]. Dr. Andrew Wolf, associate professor of medicine at the University of Virginia and lead author of the American Cancer Society's screening guideline update, has noted: "The single most important thing a person can do to prevent colorectal cancer death is to get screened starting at 45. The specific method matters far less than actually doing it" [17].

Rectal Bleeding in Specific Populations

Certain groups face distinct risks and require tailored evaluation. Pregnant women, patients on anticoagulants, and individuals with a family history of hereditary cancer syndromes all need adjusted clinical pathways.

Pregnancy. Hemorrhoids and constipation are extremely common in the second and third trimesters. Up to 35% of pregnant women report hemorrhoid symptoms [1]. Management relies on fiber, fluids, sitz baths, and safe topical agents. Most hemorrhoids regress postpartum. Rectal bleeding that is dark, mixed with stool, or associated with pain beyond typical hemorrhoid discomfort warrants further evaluation even during pregnancy.

Anticoagulation. Patients on warfarin, direct oral anticoagulants (DOACs), or antiplatelet therapy have an increased risk of GI bleeding. A 2015 meta-analysis in The Lancet found that DOACs were associated with a 25% relative reduction in major GI bleeding compared to warfarin (RR 0.75, 95% CI 0.55 to 1.03), though this varied by agent [18]. Rectal bleeding in an anticoagulated patient should never be dismissed as "just the blood thinner." It requires the same diagnostic evaluation as in non-anticoagulated patients, because the bleeding may unmask underlying pathology.

Young adults (<40). Rectal bleeding in this group is most often hemorrhoidal. The 2024 AGA Clinical Practice Guideline recommends that patients under 40 with typical hemorrhoidal bleeding and no alarm features can be managed empirically without colonoscopy [5]. Persistent or atypical bleeding, a positive FIT, or a first-degree relative diagnosed with colorectal cancer before age 60 should prompt colonoscopy regardless of age.

Hereditary syndromes. Patients with Lynch syndrome or familial adenomatous polyposis (FAP) should begin colonoscopy screening at age 20 to 25 (or 2 to 5 years before the youngest affected relative's diagnosis age), with intervals of 1 to 2 years [19].

What to Do Before Your Appointment

Note the color of the blood (bright red, dark red, maroon, or black), whether it is on the toilet paper only, in the bowl, or mixed with stool, and how many episodes have occurred. Track any associated symptoms: pain, changes in stool caliber, unintended weight loss, fatigue, or dizziness.

Stop using NSAIDs (ibuprofen, naproxen, aspirin) if you are taking them without a prescription and they are not medically necessary, as these can worsen GI bleeding. Do not stop prescribed anticoagulants or antiplatelet agents without speaking to your prescriber first.

Bring a list of all medications, including supplements and over-the-counter products. If you have a family history of colorectal cancer, polyps, or IBD, write down the specific diagnoses and the ages at which relatives were affected. Provide this information to your doctor before or during the visit to help guide the appropriate workup.

A fecal immunochemical test (FIT) can be performed at home with a kit from your doctor's office before the appointment, giving your provider actionable data at the first visit. In a 2019 study of 15,000 patients in the English FIT pilot program, FIT detected 92.4% of colorectal cancers at a hemoglobin threshold of 10 mcg/g [20].